[go: up one dir, main page]

PE20061441A1 - Genes y proteinas novedosos de brachyspira hyodysenteriae y uso de los mismos para diagnostico y terapia - Google Patents

Genes y proteinas novedosos de brachyspira hyodysenteriae y uso de los mismos para diagnostico y terapia

Info

Publication number
PE20061441A1
PE20061441A1 PE2006000496A PE2006000496A PE20061441A1 PE 20061441 A1 PE20061441 A1 PE 20061441A1 PE 2006000496 A PE2006000496 A PE 2006000496A PE 2006000496 A PE2006000496 A PE 2006000496A PE 20061441 A1 PE20061441 A1 PE 20061441A1
Authority
PE
Peru
Prior art keywords
proteins
sequence
hyodysenteriae
nos
nucleotides
Prior art date
Application number
PE2006000496A
Other languages
English (en)
Inventor
Matthew Bellgard
David John Hampson
Original Assignee
Novartis Ag
Univ Murdoch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005902418A external-priority patent/AU2005902418A0/en
Application filed by Novartis Ag, Univ Murdoch filed Critical Novartis Ag
Publication of PE20061441A1 publication Critical patent/PE20061441A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

SE REFIERE A GENES DE BRACHYSPIRA HYODYSENTERIAE QUE TIENEN LA SECUENCIA DE NUCLEOTIDOS CONTENIDA EN SEC ID NOs: 1, 3, 5, 7, 9, 11, 13; Y SECUENCIAS DE NUCLEOTIDOS QUE SEAN HOMOLOGAS A DICHA SECUENCIA EN POR LO MENOS UN 70% Y PROTEINAS DE B. HYODYSENTERIAE QUE CONTIENE LA SECUENCIA DE AMINOACIDOS CONTENIDA EN SEC ID NOs: 2, 4, 6, 8, 10, 12 Y 14, Y PROTEINAS QUE SEAN HOMOLOGAS EN AL MENOS 70% ASI COMO SECUENCIA DE NUCLEOTIDOS QUE CODIFICAN DICHAS PROTEINAS. TAMBIEN SE REFIERE A PLASMIDOS, VECTORES DE EXPRESION PROCARIOTICOS Y/O EUCARIOTICOS, Y UNA CELULA QUE CONTENGA DICHO PLASMIDO; LOS CUALES CONTIENEN ADN QUE TIENE UNA SECUENCIA QUE CODIFICAN LAS PROTEINAS QUE TIENEN DICHAS SECUENCIA DE AMINOACIDOS. UNA COMPOSICION INMUNOGENICA O VACUNA Y UN ANTICUERPO MONOCLONAL QUE SE UNE AL POLIPEPTIDO QUE CONTIENE LA SEC ID NOs: 2, 4, 6, 8, 10, 12 Y 14 Y UN EQUIPO DE DIAGNOSTICO QUE PUEDE DETECTAR LA PRESENCIA DE B. HYODYSENTERIAE EN UN ANIMAL. ESTA COMPOSICION ES UTIL PARA LA PREVENCION Y/O TRATAMIENTO DE INFECCIONES CAUSADAS POR B. HYODYSENTERIAE Y OTRAS ESPECIES TAL COMO B. ALVINIPULLI, B. AALBORGI, B. INNOCENS, ENTRE OTROS
PE2006000496A 2005-05-12 2006-05-10 Genes y proteinas novedosos de brachyspira hyodysenteriae y uso de los mismos para diagnostico y terapia PE20061441A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2005902418A AU2005902418A0 (en) 2005-05-12 Novel Genes and Proteins of Brachyspira Hyodysenteriae and Use of Same for Diagnosis and Therapy

Publications (1)

Publication Number Publication Date
PE20061441A1 true PE20061441A1 (es) 2007-01-18

Family

ID=36793884

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000496A PE20061441A1 (es) 2005-05-12 2006-05-10 Genes y proteinas novedosos de brachyspira hyodysenteriae y uso de los mismos para diagnostico y terapia

Country Status (7)

Country Link
EP (2) EP2224008A3 (es)
CN (1) CN101175856A (es)
AR (1) AR053385A1 (es)
BR (1) BRPI0611534A2 (es)
PE (1) PE20061441A1 (es)
TW (1) TW200718783A (es)
WO (1) WO2006119983A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007229002A1 (en) * 2006-03-20 2007-09-27 Murdoch University Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
WO2007113001A2 (en) * 2006-04-03 2007-10-11 Murdoch University Novel brachyspira pilosicoli genes and proteins and uses thereof
MX2010001381A (es) * 2007-08-03 2010-09-14 Spirogene Pty Ltd Genes y proteinas de brachyspira hyodysenteriae y usos de los mismos.
BRPI0909388A2 (pt) * 2008-03-27 2016-07-19 Spirogene Pty Ltd sequências de brachyspira, composições imunogênicas, métodos para a preparação e uso das mesmas
TW201302779A (zh) * 2011-04-13 2013-01-16 Glaxosmithkline Biolog Sa 融合蛋白質及組合疫苗
CN102373277B (zh) * 2011-10-27 2013-01-02 中华人民共和国北京出入境检验检疫局 一种检测猪痢疾的pcr试剂盒及引物
CN102373276B (zh) * 2011-10-27 2013-02-20 中华人民共和国北京出入境检验检疫局 一种检测猪痢疾的实时荧光pcr试剂盒及寡核苷酸序列
DK2935314T3 (da) 2012-12-21 2022-08-15 Boehringer Ingelheim Vetmedica Gmbh Nye rekombinante ydre membranproteiner fra Brachyspira hyodysenteriae og anvendelser deraf
JP2014087340A (ja) * 2013-10-24 2014-05-15 Boehringer Ingelheim Vetmedica Gmbh ブラキスピラ・ヒオディセンテリアの新規な遺伝子とタンパク質及びその使用

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654090A (en) 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
USRE31006E (en) 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4491632A (en) 1979-10-22 1985-01-01 The Massachusetts General Hospital Process for producing antibodies to hepatitis virus and cell lines therefor
US4444887A (en) 1979-12-10 1984-04-24 Sloan-Kettering Institute Process for making human antibody producing B-lymphocytes
US4342566A (en) 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
EP0043718B1 (en) 1980-07-07 1984-11-28 National Research Development Corporation Improvements in or relating to cell lines
US4341761A (en) 1980-07-25 1982-07-27 E. I. Du Pont De Nemours And Company Antibodies to immunogenic peptides and their use to purify human fibroblast interferon
US4466917A (en) 1981-02-12 1984-08-21 New York University Malaria vaccine
US4493890A (en) 1981-03-23 1985-01-15 Miles Laboratories, Inc. Activated apoglucose oxidase and its use in specific binding assays
US4451570A (en) 1981-03-26 1984-05-29 The Regents Of The University Of California Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line
US4399121A (en) 1981-11-04 1983-08-16 Miles Laboratories, Inc. Iodothyronine immunogens and antibodies
US4427783A (en) 1981-12-14 1984-01-24 Hoffmann-La Roche Inc. Immunoassay of thymosin α1
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
CA1319101C (en) 1986-09-03 1993-06-15 Marta Iris Sabara Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules
US6673776B1 (en) 1989-03-21 2004-01-06 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
ZA918426B (en) 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
EP0486106A3 (en) 1990-11-16 1992-12-23 Akzo N.V. Marek's disease virus vaccine
US6034298A (en) 1991-08-26 2000-03-07 Prodigene, Inc. Vaccines expressed in plants
US5612487A (en) 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
IL103530A0 (en) * 1991-10-25 1993-03-15 Duphar Int Res Treponema hyodysenteriae vaccine
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5712118A (en) 1993-09-29 1998-01-27 Research Foundation Of State University Of New York Vaccine for branhamella catarrhalis
US5877159A (en) 1995-05-03 1999-03-02 University Of Maryland At Baltimore Method for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the same
US6682729B1 (en) 1995-05-03 2004-01-27 University Of Maryland, Baltimore Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
US6150170A (en) 1998-05-03 2000-11-21 University Of Maryland At Baltimore Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
US5824538A (en) 1995-09-06 1998-10-20 The United States Of America As Represented By The Secretary Of The Army Shigella vector for delivering DNA to a mammalian cell
SE9602545L (sv) 1996-06-25 1997-12-26 Michael Mecklenburg Metod för att diskriminera komplexa biologiska prover
WO1998049557A1 (en) 1997-04-28 1998-11-05 B-E Safe, Inc. Taxonomic identification of microorganisms, proteins and peptides involved in vertebrate disease states
WO1999018221A1 (en) 1997-10-07 1999-04-15 University Of Maryland Biotechnology Institute Method for introducing and expressing rna in animal cells
EP1159414A4 (en) 1999-09-24 2003-08-27 Cyto Pulse Sciences Inc METHOD FOR INCREASING THE INTEGRATION OF BIOLOGICAL MATERIALS IN CELLS BROUGHT BY AN ELECTRICAL FIELD
WO2001066138A2 (en) 2000-03-07 2001-09-13 U.S. Army Medical Research Institute Of Infectious Diseases Dna vaccines against poxviruses
AU2001250859A1 (en) 2000-03-16 2001-09-24 Joseph J. Drabick Method for gene transfection and vaccination through skin using electropermeabilization
US20050163791A1 (en) * 2002-05-08 2005-07-28 Ben Adler Brachyspira hyodysenteriae vaccine
AU2003250057B2 (en) * 2002-07-17 2008-02-14 Intervet International B.V. Brachyspira hyodysenteriae vaccine
AU2002953431A0 (en) * 2002-12-19 2003-01-09 Murdoch University BmpB Novel Nucleotide and Amino Acid Sequences and Diagnostic and Therapeutic Uses Thereof

Also Published As

Publication number Publication date
TW200718783A (en) 2007-05-16
EP2224008A2 (en) 2010-09-01
WO2006119983A2 (en) 2006-11-16
BRPI0611534A2 (pt) 2010-09-21
EP2224008A3 (en) 2010-12-01
EP1882035A2 (en) 2008-01-30
WO2006119983A3 (en) 2007-04-05
CN101175856A (zh) 2008-05-07
AR053385A1 (es) 2007-05-02

Similar Documents

Publication Publication Date Title
AR064642A1 (es) Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
AR072680A1 (es) Axmi-115 axmi-113 axmi-005 axmi-163 y axmi-184 proteinas insecticidas y metodos de uso de las mismas
PE20210376A1 (es) Peptidos y combinacion de peptidos de origen no canonico para el uso en la inmunoterapia contra diferentes tipos de cancer
AR052441A1 (es) Suspension no acuosa inyectable
MX2020001328A (es) Muteinas de interleucina 21 y metodos de tratamiento.
BRPI0612273A2 (pt) anticorpo de ligaÇço a il-1 beta ou fragmento de ligaÇço a il-1 beta do mesmo, Ácido nucleico, vetor, cÉlula, animal transgÊnico, hibridoma, composiÇço, e, mÉtodos de tratamento ou prevenÇço de uma doenÇa ou doenÇa relacionada a il-1 em um mamÍfero, e de preparaÇço de um polipeptÍdeo de ligaÇço a il-1 beta maturado por afinidade
EP1548032A4 (en) KDR-PEPTIDES AND VACCINES CONTAINING THEM
BR0013542A (pt) Moléculas b7-4 e usos para as mesmas
AR051444A1 (es) Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
PE20061040A1 (es) Anticuerpos antiamiloides humanizados
AR038568A1 (es) Anticuerpos anti-a beta y su uso
CO5700788A2 (es) Composiciones y metodos para inmunoterapia especifica de wt1
ES2353814T3 (es) Proteinas n-glicosiladas recombinantes de celulas procariotas.
ATE443161T1 (de) Mittel und verfahren für den nachweis von methylierter dna
WO2007133623A3 (en) Peptide diagnostic agent for lyme disease
EA201100070A1 (ru) Туберкулезный белок rv2386c, композиции и их применения
AR042968A1 (es) Anticuerpos de virus anti-dengue composiciones metodos y usos
EA201100071A1 (ru) Новые композиции и способы
PE20061441A1 (es) Genes y proteinas novedosos de brachyspira hyodysenteriae y uso de los mismos para diagnostico y terapia
BR9913652A (pt) Gene e proteìna antigênica imunodominante de 120 kda de ehrlichia canis
HRP20130022T1 (hr) Fuzijski proteini koji sadrže antigene ny-eso-1 i lage-1 za odbacivanje tumora
CO6260101A2 (es) Nuevos genes y proteinas de branchyspira hyodysenteriae y el uso de los mismos
UA122856C2 (uk) Варіантний інсектицидний ген ахмі115 та способи його застосування
ATE520708T1 (de) Immunogenetische hiv-1 multi-klade, multivalente konstrukte und deren verwendung
BR9710849A (pt) Vacina contendo uma peróxi-redoxina e/ou uma beta-tubulina.

Legal Events

Date Code Title Description
FX Voluntary withdrawal